Manufactures specialty and essential chemicals, with FY26 revenue of Rs 2,846.67 crore split between Essential Chemicals (71% of turnover) and Specialty Chemicals (29%), as disclosed in the FY26 BRSR. The Essentials business is built around ethyl acetate and acetic acid, with a world-scale ethyl acetate line at Lote (Maharashtra) commissioned in May 2026 and customer dispatches already underway. The Specialties business covers ketene/diketene, fluorinated products, and India's first commercial-scale Electrochemical Fluorination facility at Lote; Dahej Phase 2 ketene/diketene capacity is in chemical charging in Q1 FY27 with first revenues flagged from H2 FY27. End-uses cited across calls include pharma, printing & packaging, industrial solutions, and pigments, and a multi-year contract with Hitachi Energy covers SF6-free gas for grid equipment, with the project scheduled to commence in Q2 FY27. Materials are the dominant cost at 65.2% of revenue, with acetic acid and methanol as the key volatile inputs — acetic acid spiked above $700/tonne in March before moderating to $450-470. Exports contributed 32.11% of revenue across 56 countries in FY26, and the workforce totals 1,913 people (1,098 employees plus 815 workers). AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Essential Chemicals (71%), Specialty Chemicals (29%). Cyclical, commodity-tied specialty chemicals with volatile input spreads
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,084 | 2,797 | 2,865 | 2,985 | 2,847 |
| EBITDA (ex other income) | 368 | 245 | 256 | 280 | 171 |
| margin % | 11.9 | 8.7 | 8.9 | 9.4 | 6.0 |
| Owners' profit | 256 | 125 | 121 | 114 | 0 |
| EPS, as reported (₹) | 9.72 | 4.70 | 4.46 | 4.10 | 2.87 |
| ROE % · ROCE % | 19.7 · 25.0 | 8.8 · 11.6 | 6.7 · 9.2 | 6.0 · 9.1 | 4.0 · 4.4 |
| Debt / equity (x) | 0.10 | 0.28 | 0.08 | 0.13 | 0.27 |
| Cash from operations | 46 | 199 | 562 | 108 | 180 |
| Capex | (289) | (476) | (248) | (394) | (602) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 771 | 786 | 710 | 693 | 700 | 719 | 735 | 968 |
| Profit before tax | 46 | 47 | 13 | 14 | 15 | 26 | 32 | 92 |
| Net profit | 28 | 29 | 22 | 21 | 11 | 25 | 22 | 68 |
| EPS (₹) | 1.01 | 1.06 | 0.79 | 0.77 | 0.41 | 0.92 | 0.77 | 2.44 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,59,479 | 60.2 | 14.43 | 42.3 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 73,583 | 34.0 | 5.24 | 22.7 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 52,514 | 85.7 | 6.64 | 41.5 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,836 | 55.4 | 11.03 | 39.5 | 16.7 | 16.4 | 23.0 | 37.5 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · Laxmi Organic MD and CEO transition: Goenka replaces Dr. Venkatesh | management changes | high | — | — |
| 18 Aug 2026 · Two Senior Management Personnel resign from Laxmi Organic | management changes | medium | — | — |
| 18 Aug 2026 · Two senior leaders resign; no direct replacements planned | management changes | medium | — | — |
| 18 Aug 2026 · Two senior leaders resign from Laxmi Organic; CPO and CTO to exit by Oct 31, 2026 | management changes | high | — | — |
| 13 Aug 2026 · Laxmi Organic allots 7.03 lakh shares under ESOP-2020 to employees | capital market events | low | — | — |
| 7 Aug 2026 · AGM 2026: All 6 resolutions passed; final dividend declared | compliance | minimal | — | — |
| 5 Aug 2026 · 37th AGM proceedings: dividend, director re-appointments, executive pay approved | board shareholder meetings | medium | — | — |
| 4 Aug 2026 · Laxmi Organic Q1 FY27 Transcript: Revenue Up 40%, EBITDA Up 272% YoY | investor communications | medium | — | — |
| 31 Jul 2026 · Laxmi Organic Q1 FY27 net profit jumps over 3x YoY to Rs 6.77 cr | compliance | minimal | — | — |
| 30 Jul 2026 · QIP proceeds monitoring report for Q1 FY27 shows no deviation | fund raising | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| AETHER INDUSTRIES LIMITED | 22,229 | 94.3 | 9.05 | 60.4 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,769 | 27.8 | 3.71 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| ATUL LTD | 18,401 | 23.1 | 2.92 | 14.9 | 10.9 | 13.3 | 10.9 | 23.1 |
| AARTI INDUSTRIES LTD | 17,846 | 33.6 | 3.00 | 18.8 | 7.0 | 4.4 | 13.0 | 16.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 38.7 | 23.4 | 76 of 103 | 27% |
| P/B | 2.5 | 2.9 | 39 of 99 | 61% |
| ROCE | 3.5 | 10.3 | 87 of 108 | 20% |
| ROE | 4.0 | 8.1 | 77 of 101 | 24% |
| Debt / Equity | 0.3 | 0.2 | 62 of 101 | 39% |
| EBITDA margin | 12.2 | 15.5 | 64 of 99 | 36% |
| Revenue growth | 39.8 | 24.4 | 23 of 94 | 76% |
| Profit growth | 216.6 | 55.1 | 14 of 92 | 86% |
| Market cap | 4871 | 732 | 26 of 107 | 76% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
